| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |